1703-07-7

基本信息
6-氯-5-甲基噠嗪-3-酮
6-氯-5-甲基噠嗪-3(2H)-酮
6-氯-5-甲基-2H-吡嗪-3-酮
6-氯-5-甲基-2H-噠嗪-3-酮
6-chloro-5-methylpyridazine-3-one
3-chloro-4-methyl-1H-pyridazin-6-one
6-Chloro-5-Methylpyridazin-3(2H)-one
6-chloro-5-methyl-2H-pyridazin-3-one
6-Chloro-3-hydroxy-5-methylpyridazine
3(2H)-Pyridazinone, 6-chloro-5-Methyl-
6-Chloro-3-hydroxy-5-methylpyridazine 97%
6-Chloro-5-methylpyridazin-3-ol, 6-Chloro-3-hydroxy-5-methyl-1,2-diazine
物理化學(xué)性質(zhì)
制備方法

19064-64-3

1834-27-1

1703-07-7
在室溫下,將3,6-二氯-4-甲基噠嗪(30.6 g,190 mmol)懸浮于冰乙酸(800 mL)中,隨后置于110-115°C的油浴中加熱3小時(shí)(反應(yīng)1小時(shí)后混合物變?yōu)榫啵?。反?yīng)完成后,將混合物冷卻至室溫,并通過減壓蒸餾除去乙酸。將得到的固體殘余物緩慢加入飽和碳酸氫鈉溶液(200 mL)中,得到淺黃色非均相混合物,隨后在劇烈攪拌下緩慢加入固體碳酸氫鈉調(diào)節(jié)至pH 6。用二氯甲烷(2×250 mL)萃取混合物,合并有機(jī)相后用飽和碳酸氫鈉水溶液洗滌,再用氯化鈉溶液(60 mL)洗滌,最后用無水硫酸鎂干燥并濃縮,得到粗產(chǎn)物(20.9 g)。通過柱色譜法純化(洗脫梯度:1%甲醇/二氯甲烷至5%甲醇/二氯甲烷),分離得到6-氯-4-甲基-2H-噠嗪-3-酮(13.4 g,92.7 mmol,產(chǎn)率49%)[Rf 0.21(2.5%甲醇/二氯甲烷)]和6-氯-5-甲基-2H-噠嗪-3-酮(5.00 g,34.6 mmol,產(chǎn)率18%)[Rf 0.11(2.5%甲醇/二氯甲烷)],均為無色固體。6-氯-4-甲基-2H-噠嗪-3-酮的核磁共振數(shù)據(jù):1H NMR(200 MHz,CDCl3-CD3OD):δ 2.12(3H,s),3.55(1H,br s),7.05(1H,s);13C NMR(50 MHz,CDCl3):δ 16.1(CH3),131.7(CH-5),139.0(C-6),143.0(C-4),161.9(C-3)。6-氯-5-甲基-2H-噠嗪-3-酮的物理和光譜數(shù)據(jù):熔點(diǎn)172-173°C(由二氯甲烷/輕質(zhì)石油醚重結(jié)晶);1H NMR(200 MHz,CDCl3):δ 2.20(3H,d,J = 1.3 Hz),7.13(1H,q,J = 1.3 Hz);13C NMR(50 MHz,CDCl3):δ 16.3(CH3),131.9(CH-5),139.2(C-4),143.2(C-6),161.9(C-3)。低分辨質(zhì)譜(EI):m/z 144([M+])。元素分析計(jì)算值(C5H5ClN2O):C,41.54;H,3.49;N,19.38。實(shí)測值:C,41.55;H,3.51;N,19.22。
參考文獻(xiàn):
[1] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 5, p. 1644 - 1658
[2] Patent: US2012/108578, 2012, A1. Location in patent: Page/Page column 26
[3] Acta Chemica Scandinavica (1947-1973), 1961, vol. 15, p. 1660,1665
[4] Pharmaceutical Bulletin, 1957, vol. 6, p. 587,589
[5] Pharmaceutical Bulletin, 1957, vol. 5, p. 229,233